Margarida L F Martins (Margarida L Ferreira Martins)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 7

Top Topics

Emergency Department

Cancer Stem Cells

Top Venues

Molecular pharmaceutics

Molecular cancer therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Nancy H C Loos, Margarida L F Martins, Jamie Rijmers, Daniëlle de Jong, Maria C Lebre, Matthijs Tibben, Jos H Beijnen, Alfred H Schinkel
Interplay of Ritonavir-Boosted Oral Cabazitaxel with the Organic Anion-Transporting Polypeptide (OATP) Uptake Transporters and Carboxylesterase 1 in Mice. Molecular pharmaceutics 21 (4) (2024)
Nancy H C Loos, Margarida L F Martins, Jamie Rijmers, Daniëlle de Jong, Maria C Lebre, Matthijs Tibben, Jos H Beijnen, Alfred H Schinkel
Interplay of Ritonavir-Boosted Oral Cabazitaxel with the Organic Anion-Transporting Polypeptide (OATP) Uptake Transporters and Carboxylesterase 1 in Mice. Molecular pharmaceutics 21 (4) (2024)
Nancy H C Loos, Margarida L F Martins, Jamie Rijmers, Daniëlle de Jong, Maria C Lebre, Matthijs Tibben, Jos H Beijnen, Alfred H Schinkel
Interplay of Ritonavir-Boosted Oral Cabazitaxel with the Organic Anion-Transporting Polypeptide (OATP) Uptake Transporters and Carboxylesterase 1 in Mice. Molecular pharmaceutics (2024)
Nancy H C Loos, Margarida L F Martins, Jamie Rijmers, Daniëlle de Jong, Maria C Lebre, Matthijs Tibben, Jos H Beijnen, Alfred H Schinkel
Interplay of Ritonavir-Boosted Oral Cabazitaxel with the Organic Anion-Transporting Polypeptide (OATP) Uptake Transporters and Carboxylesterase 1 in Mice. Molecular pharmaceutics 21 (4) (2024)
Nancy H C Loos, Margarida L F Martins, Daniëlle de Jong, Maria C Lebre, Matthijs Tibben, Jos H Beijnen, Alfred H Schinkel
Enhancement of the Oral Availability of Cabazitaxel Using the Cytochrome P450 3A (CYP3A) Inhibitor Ritonavir in Mice. Molecular pharmaceutics (2023)
Wenlong Li, Rolf W Sparidans, Margarida L F Martins, Mujtaba El-Lari, Maria C Lebre, Olaf van Tellingen, Jos H Beijnen, Alfred H Schinkel
ABCB1 and ABCG2 Restrict Brain and Testis Accumulation and, Alongside CYP3A, Limit Oral Availability of the Novel TRK Inhibitor Selitrectinib. Molecular cancer therapeutics 20 (6) (2021)
Margarida L F Martins, Nancy H C Loos, Sümeyra Mucuk, Danielle de Jong, Maria C Lebre, Hilde Rosing, Matthijs Tibben, Jos H Beijnen, Alfred H Schinkel
P-Glycoprotein (ABCB1/MDR1) Controls Brain Penetration and Intestinal Disposition of the PARP1/2 Inhibitor Niraparib. Molecular pharmaceutics 18 (12) (2021)